1-(Piperidin-4-yl)pyrrolidin-2-one hydrochloride, 95.0%, 250mg

5-Bromo-2-fluoro-3-methylbenzaldehyde, 95.0%, 5g

1-(pyridin-2-yl)but-3-en-1-ol, 95.0%, 500mg

Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate, 95+%, 1g

4-Ethoxyphenylboronic acid, 97.0%, 5g

Zernike phase contrast set PLPH 10/20/40/100 bright field and dark field position

10-CHLORO-10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPINE-5-CARBOXAMIDE, 95.0%, 250mg

4-[(3-Chlorophenyl)amino]-4-oxobutanoic acid, 95.0%, 250mg

2,5-Dichloroquinoxaline, 95.0%, 25g

5-Fluoro-3-methoxypyridin-2-amine, 95.0%, 1g

5-(4-methylbenzyl)-1,3,4-thiadiazol-2-amine, 95.0%, 1g

(2E)-3-(3-FORMYL-4-HYDROXYPHENYL)PROP-2-ENOIC ACID, 95%, 250mg

N,N-Diethylpropionamide, 95.0%, 25ml